Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushenqiangji prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by the Sichuan Bayi Rehabilitation Center (Sichuan Provincial Rehabilitation Hospital) for the treatment of lumbar disc herniation, particularly in older adults. The formula is designed based on the TCM principle of "tonifying the kidney and strengthening the spine" (Bushen Qiangji) to address degenerative changes in the lumbar spine. In clinical settings, it is often evaluated as part of a comprehensive rehabilitation program that includes chiropractic adjustments and acupuncture. The prescription aims to reduce pain, improve lumbar function, and enhance the quality of life for patients suffering from disc-related disability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushenqiangji prescription.